Can­nara Biotech to trade on CSE Jan. 14

Stockwatch Daily - - CONSUMER GOODS -

CSE BUL­LETIN 2019-0111 The com­mon shares of Can­nara Biotech Inc. have been ap­proved for list­ing on the Cana­dian Se­cu­ri­ties Ex­change.

List­ing and dis­clo­sure doc­u­ments will be avail­able on the CSE web­site on the trad­ing date.

Can­nara Biotech is a ver­ti­cally in­te­grated cannabis com­pany build­ing the largest indoor cannabis cul­ti­va­tion facility in Que­bec, a mod­ern and se­cure 625,000-square­foot facility. Lev­er­ag­ing Que­bec’s low elec­tric­ity costs, Can­nara Biotech will pro­duce high-grade indoor cannabis, spe­cial­iz­ing in de­riv­a­tive prod­ucts and brands.

- Is­suer: Can­nara Biotech - Se­cu­rity type: com­mon shares

- Sym­bol: LOVE

- Num­ber of se­cu­ri­ties is­sued and out­stand­ing: 693,820,705

- Num­ber of se­cu­ri­ties re­served for is­suance: 44,899,267

- CSE sec­tor: life sciences - Cusip No.: 13765U 10 1 - ISIN: CA 13765U 10 1 2

- Board lot: 500 - Trad­ing cur­rency: Cana­dian dol­lar

- Trad­ing date: Jan. 14, 2019

- Other ex­changes: not ap­pli­ca­ble

- Fis­cal year-end: Aug. 31

- Trans­fer agent: Com­put­er­share In­vestor Ser­vices Inc.

The ex­change is ac­cept­ing mar­ket-maker ap­pli­ca­tions for LOVE.

Zo­har Kriv­o­rot, Amy Joy Sa­tov, Derek Stern, Be­sar Xhelili

(LOVE) Shares: 693,820,705

Newspapers in English

Newspapers from Canada

© PressReader. All rights reserved.